The technology behind the COVID-19 vaccines may be headed for an even bigger fight. A cancer treatment that uses messenger RNA to launch an immune attack on cancer cells completely shrank tumors in mice — and has moved into testing in people.

Photo: FreddyO / Facebook.
Messenger RNAs — mRNAs — are molecules that instruct cells to make specific proteins. They became household knowledge with the rollout of the mRNA COVID-19 vaccines, which teach the body to recognize and fight the virus.
BioNTech, the German company that developed Pfizer’s mRNA COVID vaccine, is now testing whether the same approach can be turned against cancer — training the immune system to recognize and attack tumor cells.
Early results in mice showed tumors shrinking completely. Human trials are the critical next step, and researchers are watching closely: if it works in people the way it worked in the lab, mRNA could open a whole new front in cancer treatment.
Sources: New Scientist · Original FreddyO Facebook post























Leave a Reply